Mullen Automotive Secures Major European Order for Delivery EVs
- New European Purchase Order: Mullen Automotive secures a purchase order for 40 Mullen-GO urban delivery vehicles from Antidoto SA in Switzerland.
- Order Details: The initial purchase order is valued at $0.44 million, with plans for more orders in the future.
- Expansion Plans: Antidoto SA intends to order a minimum of 180 units for 2025 and will initially deploy 40 vehicles in Switzerland.
- Collaboration Benefits: Antidoto SA believes that collaborating with Mullen could enhance their production capacity by offering electric vehicles to customers.
- Stock Update: Mullen Automotive's stock has decreased significantly over the past year, but investors can access it through specific ETFs.
Trade with 70% Backtested Accuracy
Analyst Views on VXF
About the author

VolitionRx Share Price Drop: VolitionRx (VNRX) shares fell over 34% in pre-market trading following the announcement of proof-of-concept data from a blinded validation cohort for cancer detection.
New Liquid Biopsy Method: The company revealed a new liquid biopsy method that achieved over 95% sensitivity for stage I & II cancers, with 95% specificity during the blinded validation cohort.
Retail Sentiment: Retail sentiment around VolitionRx trended bullish, with message volumes reported at extremely high levels at the time of writing.
Updates and Corrections: For ongoing updates and corrections related to this story, readers are encouraged to check Stocktwits.
Stock Price Decline: Shares of Energoous Corporation (WATT) fell by 5% following a report from Fugazi Research that labeled the company as a "business funded by dilution."
Business Model Critique: Fugazi highlighted that Energoous has not built a self-sustaining business over the past decade, relying instead on shareholder funding.
Investment Viability: The firm described Energoous as "uninvestable," suggesting that it may turn current shareholders into "bagholders" due to the company's financial model.
Future Outlook: There are concerns that shares may revert to single-digit pricing, indicating a potential decline in value for investors.

CEO Exit Package Controversy: YZ Labs criticized the company's board for approving a nearly $2 million exit package for outgoing CEO David Namdar, raising concerns about transparency and accountability amidst reported weaknesses in financial controls.
Allegations of Mismanagement: YZ Labs accused CEA Industries of serious mismanagement, including questionable insider payments and excessive related-party transactions, which they claim could lead to conflicts of interest and undermine investor confidence.
Call for Transparency: The firm demanded greater transparency and accountability from the board, particularly regarding the CEO's exit package and internal control deficiencies, emphasizing the need for a clear remediation plan.
Stock Performance and Market Sentiment: CEA Industries' stock saw a rise of 1.94% amid ongoing retail sentiment, while YZ Labs highlighted concerns over the company's governance practices, likening it to a "piggy bank" operation rather than a publicly accountable entity.

Partnership Announcement: Mobileye Global Inc. has secured a deal with a leading U.S. automaker to integrate its Driver Monitoring System into future vehicles equipped with Mobileye's EyeQ6 system, with production targeted for 2027.
Market Reaction: Following the announcement, Mobileye's shares rose by over 8% in pre-market trading, reflecting positive retail sentiment around the company.
Previous Collaboration: Tesla previously partnered with Mobileye to develop the Autopilot driving system, but their partnership ended in 2016 when Mobileye collaborated with BMW instead.
Future Developments: Updates on this story will be available directly on Stocktwits, indicating ongoing interest and potential developments in the autonomous driving sector.
Acquisition Details: Agero, Inc. is acquiring Urgently, Inc. for $5.50 per share, representing a premium of approximately 171% from Urgently's closing price on Thursday. The merger is expected to close by the end of May 2026, pending customary closing conditions.
Company Background: Urgently is a U.S.-based provider of technology-focused roadside and mobility assistance solutions, while Agero aims to enhance its ecosystem by combining technologies, talent, and scale from both companies.
Financial Performance: Agero reported a 4% year-over-year revenue growth to $33.3 million, with adjusted operating income at $0.2 million, a significant improvement from a $3 million loss in the same quarter last year.
Market Reaction: Following the acquisition announcement, Urgently's stock rose by 161% after hours, while overall sentiment around the stock shifted from bearish to bullish, despite a 44% drop over the past 12 months.

Board's Recommendation: Blue Owl Capital Corporation II's Board of Directors has unanimously recommended that shareholders reject an unsolicited minority tender offer from Cox Capital Partners and Sabra Capital Management for up to 8 million shares at approximately $30 million, citing a significant discount to the company's estimated long-term asset value.
Valuation Concerns: The Board believes the tender offer undervalues the company's assets and ongoing access to liquidity, representing a discount of about 33.2% to the net asset value, which is below their assessment of the potential long-term value of the shares.
Consultation Process: In reaching its conclusion, the Board consulted with management and its financial and legal advisors, reviewing the terms and conditions of the offer and considering the fund's historical financial performance and future opportunities.
Market Reaction: Retail sentiment around Blue Owl has been low, with shares falling 41.5% so far in 2026, reflecting a negative market response to the tender offer and overall company performance.





